Turn Therapeutics (TTRX) Intangibles (2024 - 2026)

Turn Therapeutics' (TTRX) quarterly Intangibles came in at $919947.0 in Q1 2026, little changed quarter-over-quarter from $922171.0 in Q4 2025.

Turn Therapeutics (TTRX) Intangibles (2024 - 2026) Analysis & Trends

Turn Therapeutics' Intangibles history runs 3 years deep, the most recent figure standing at $919947.0 for Q1 2026.

  • On a quarterly basis, Intangibles changed N/A year-over-year to $919947.0 in Q1 2026; TTM through Mar 2026 was $919947.0, a N/A change from a year earlier, with the FY2025 full-year figure at $922171.0, up 12.2% from the prior year.
  • Intangibles was little changed at $919947.0 in Q1 2026 per TTRX's latest filing, from $922171.0 in the prior quarter.
  • Across five years, Intangibles topped out at $922171.0 in Q4 2025 and bottomed at $821931.0 in Q4 2024.
  • The 3-year median for Intangibles is $912416.0 (2025), against an average of $892233.5.
  • Biggest YoY gain for Intangibles was 12.2% in 2025; the steepest drop was 12.2% in 2025.
  • Year by year, Intangibles stood at $821931.0 in 2024, then climbed by 12.2% to $922171.0 in 2025, then declined by 0.24% to $919947.0 in 2026.
  • Per Business Quant, the three latest TTRX Intangibles figures stand at $919947.0 (Q1 2026), $922171.0 (Q4 2025), and $904885.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 16.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 11,640.44
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 61.68 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.92 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 418.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.29 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 266.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 55.80 Mn
10 Turn Therapeutics 282.39 Mn 282.39 Mn - 919,947.00

Historic Data

Download Data
DateValue
Mar 31, 2026 919,947.00
Dec 31, 2025 922,171.00
Sep 30, 2025 904,885.00
Dec 31, 2024 821,931.00